Krilogy Financial LLC Novartis Ag Transaction History

Krilogy Financial LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 27, 2022	SELL	$79.7 - $88.13 $1.16 Million - $1.28 Million	-14,550 Closed	0 $0
Q3 2021 Oct 25, 2021	BUY	$81.78 - $95.14 $12,103 - $14,080	148 Added 1.03%	14,550 $1.19 Million
Q2 2021 Jul 20, 2021	BUY	$85.24 - $94.15 $50,888 - $56,207	597 Added 4.32%	14,402 $1.31 Million
Q1 2021 Apr 21, 2021	BUY	$83.5 - $98.47 $482,463 - $568,959	5,778 Added 71.98%	13,805 $1.18 Million
Q4 2020 Feb 11, 2021	BUY	$78.07 - $94.43 $36,927 - $44,665	473 Added 6.26%	8,027 $758,000
Q3 2020 Nov 13, 2020	SELL	$82.14 - $91.0 $120,006 - $132,951	-1,461 Reduced 16.21%	7,554 $657,000
Q2 2020 Aug 06, 2020	BUY	$80.93 - $91.1 $729,583 - $821,266	9,015 New	9,015 $787,000
Q4 2018 Feb 14, 2019	SELL	$73.66 - $82.02 $84,782 - $94,405	-1,151 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$66.94 - $77.43 $77,047 - $89,121	1,151 New	1,151 $99,000
Q2 2018 Aug 15, 2018	SELL	$64.91 - $73.36 $42,321 - $47,830	-652 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$70.39 - $84.15 $9,291 - $11,107	132 Added 25.38%	652 $53,000
Q3 2017 Nov 15, 2017	BUY	$74.14 - $77.27 $2,075 - $2,163	28 Added 5.69%	520 $45,000
Q2 2017 Aug 15, 2017	BUY	N/A	492	492 $41,000

1,434

133M

1.12M

1.82M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $225B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Krilogy Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Krilogy Financial LLC with notifications on news.